ArticleCancer research2023

LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Sunny Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.